Lila Glotfelty, MD, PhD (she/her/hers)

Sanofi

Poster(s):

• P0198 - A Phase 2 Study Design to Investigate the Efficacy and Safety of Dupilumab Therapy Compared With Placebo in Adults With Moderately to Severely Active Ulcerative Colitis With an Eosinophilic Phenotype
  Sunday, October 22, 2023

  3:30 PM – 7:00 PM PT